How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

116,678 results for

OBESITY

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Text messaging to help women with overweight or obesity lose weight after childbirth: the intervention adaptation and SMS feasibility RCT Full Text available with Trip Pro

Text messaging to help women with overweight or obesity lose weight after childbirth: the intervention adaptation and SMS feasibility RCT Text messaging to help women with overweight or obesity lose weight after childbirth: the intervention adaptation and SMS feasibility RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation (...) or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} This study successfully developed a text messaging intervention that was acceptable to postpartum women with overweight or obesity, and a full trial is feasible. {{author}} {{($index , , , , , , , , , , , , , & . Caroline McGirr 1 , Ciara Rooney 1 , Dunla Gallagher 1 , Stephan U Dombrowski 2 , Annie S Anderson 3 , Christopher R Cardwell

2020 NIHR HTA programme

2. Interventions for supporting the initiation and continuation of breastfeeding among women who are overweight or obese. Full Text available with Trip Pro

Interventions for supporting the initiation and continuation of breastfeeding among women who are overweight or obese. Exclusive breastfeeding is recommended for all infants until six months of age due to the many health benefits for both the mother and infant.Evidence suggests that mothers who are overweight (body mass index (BMI) 25.0 to 29.9 kg/m²) or obese (BMI ≥ 30.0 kg/m²) are less likely to initiate breastfeeding and to breastfeed for a shorter duration. Considering the rising prevalence (...) of overweight and obesity globally and the known benefits of breastfeeding particularly in reducing the long-term risks of obesity and diabetes for infants, establishing effective ways to support and promote breastfeeding in women who are overweight or obese is paramount in achieving the goal of healthier communities.To assess the effectiveness of interventions to support the initiation or continuation of breastfeeding in women who are overweight or obese.On 23 January 2019 we searched Cochrane Pregnancy

2019 Cochrane

3. Improving the assessment and management of obesity in UK children and adolescents: the PROMISE research programme including a RCT Full Text available with Trip Pro

Improving the assessment and management of obesity in UK children and adolescents: the PROMISE research programme including a RCT Improving the assessment and management of obesity in UK children and adolescents: the PROMISE research programme including a RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website (...) search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} This research programme included five linked studies relating to childhood obesity, one of which found that the Healthy Eating and Lifestyles Programme for obese adolescents did not reduce BMI after 6 months. {{author}} {{($index , , , , , , , , , , , , , , , , & . Russell M Viner 1, * , Sanjay Kinra 2 , Deborah Christie 3 , Tim J Cole 4 , Silvia Costa

2020 NIHR HTA programme

4. An app-, web- and social support-based weight loss intervention for adults with obesity: the HelpMeDoIt! feasibility RCT Full Text available with Trip Pro

An app-, web- and social support-based weight loss intervention for adults with obesity: the HelpMeDoIt! feasibility RCT An app-, web- and social support-based weight loss intervention for adults with obesity: the HelpMeDoIt! feasibility RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above

2020 NIHR HTA programme

5. Endoscopic placement and removal of an intra-gastric balloon (IGB) for the management of overweight and obesity in a high-risk patient

Endoscopic placement and removal of an intra-gastric balloon (IGB) for the management of overweight and obesity in a high-risk patient 1 Public Summary Document Application No. 1515 Endoscopic placement and removal of an intragastric balloon for the management of moderate obesity in patients with type 2 diabetes mellitus who have failed first-line treatments Applicant: Apollo Endosurgery Australia Date of MSAC consideration: MSAC 76 th Meeting, 1-2 August 2019 Context for decision: MSAC makes (...) its advice in accordance with its Terms of Reference, visit the MSAC website 1. Purpose of application An application requesting Medicare Benefits Schedule (MBS) listing of the endoscopic placement and removal of an intragastric balloon (IGB) for the treatment of patients aged = 18 years with moderate obesity (body mass index (BMI) of 30.0 to 34.9 kg/m 2 ), who have poorly controlled type 2 diabetes mellitus (T2DM) and who have failed first-line treatment options, was received from Apollo

2019 Medical Services Advisory Committee

6. Obese, overweight with risk factors: liraglutide (Saxenda)

Obese, overweight with risk factors: liraglutide (Saxenda) Obese, o Obese, ov verweight with risk factors: lir erweight with risk factors: liraglutide aglutide (Sax (Saxenda) enda) Evidence summary Published: 27 June 2017 nice.org.uk/guidance/es14 pathways K Ke ey points y points The content of this evidence summary was up-to-date in June 2017. See summaries of product characteristics (SPCs), British national formulary (BNF) or the MHRA or NICE websites for up- to-date information. Regulatory (...) status: Regulatory status: New medicine. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Liraglutide (Saxenda) received a European marketing authorisation in March 2015 and was launched in the UK in January 2017. It is licensed as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with an initial BMI of: 30 kg/m² or more (obese), or from 27 kg/m² to less than 30 kg/m² (overweight) in the presence of at least one weight

2017 National Institute for Health and Clinical Excellence - Advice

7. A review of the evidence base for modelling the costs of overweight, obesity and diet-related illness for Scotland, and critical appraisal of the cost-effectiveness evidence base for population wide interventions to reduce overweight, obesity and diet-rel

A review of the evidence base for modelling the costs of overweight, obesity and diet-related illness for Scotland, and critical appraisal of the cost-effectiveness evidence base for population wide interventions to reduce overweight, obesity and diet-rel 1 A review of the evidence base for modelling the costs of overweight, obesity and diet-related illness for Scotland, and critical appraisal of the cost-effectiveness evidence base for population wide interventions to reduce overweight (...) of methods 10 1.4 Structure of the report 10 2 Evidence base relating to the costs of overweight, obesity and diet-related illness 11 2.1 Overview of cost of illness methods 11 Figure 1 Overview of costs 12 2.2 Literature search 14 Figure 2 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta- Analyses) flow chart of cost of illness studies 16 Included 16 Eligibility 16 Screening 16 Identification 16 2.3 Results and critical appraisal 17 2.4 Summary and conclusions 22 3 Cost-effectiveness

2017 Health Economics Research Unit

8. Naltrexone?bupropion for managing overweight and obesity

Naltrexone?bupropion for managing overweight and obesity Naltre Naltrex xone–bupropion for managing one–bupropion for managing o ov verweight and obesity erweight and obesity T echnology appraisal guidance Published: 12 December 2017 nice.org.uk/guidance/ta494 © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guidance represent the view of NICE (...) . Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Naltrexone–bupropion for managing overweight and obesity (TA494) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 17Contents Contents 1 Recommendations 4 2 The technology 5 3 Committee discussion 6

2017 National Institute for Health and Clinical Excellence - Technology Appraisals

9. Childhood obesity: applying All Our Health

Childhood obesity: applying All Our Health Childhood obesity: applying All Our Health - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search The United Kingdom is leaving the European Union on 31 October 2019. Guidance Childhood obesity: applying All Our Health Evidence and guidance on childhood obesity, to help families and communities intervene and help change eating and activity habits. Published 1 April 2015 Last

2020 Public Health England

10. Overweight, Obesity and Contraception

Overweight, Obesity and Contraception FSRH Guideline Overweight, Obesity & Contraception April 2019 | FSRH Faculty of Sexual & Reproductive Healthcare (FSRH) provided funding to the Clinical Effectiveness Unit (of the FSRH) to assist them in the production of this guideline, Overweight, Obesity and Contraception (April 2019). Published by the Faculty of Sexual & Reproductive Healthcare. Registered in England No. 2804213 and Registered Charity No. 1019969. Copyright © Faculty of Sexual (...) . If a guideline is updated, the FSRH replace the version on its website and the BMJ Sexual & Reproductive Health (BMJ SRH) journal will ensure old versions of guidelines will clearly signpost the newer version. iii Copyright ©Faculty of Sexual & Reproductive Healthcare 2019 FSRH guideline: Overweight, Obesity and Contraception Abbreviations used BMD bone mineral density BMI body mass index CEU Clinical Effectiveness Unit CHC combined hormonal contraception/contraceptive CI confidence interval COC combined

2019 Faculty of Sexual & Reproductive Healthcare

11. Interventions for preventing obesity in children. Full Text available with Trip Pro

, or both, designed to prevent obesity in children.We searched CENTRAL, MEDLINE, Embase, PsychINFO and CINAHL in June 2015. We re-ran the search from June 2015 to January 2018 and included a search of trial registers.Randomised controlled trials (RCTs) of diet or physical activity interventions, or combined diet and physical activity interventions, for preventing overweight or obesity in children (0-17 years) that reported outcomes at a minimum of 12 weeks from baseline.Two authors independently (...) Interventions for preventing obesity in children. Prevention of childhood obesity is an international public health priority given the significant impact of obesity on acute and chronic diseases, general health, development and well-being. The international evidence base for strategies to prevent obesity is very large and is accumulating rapidly. This is an update of a previous review.To determine the effectiveness of a range of interventions that include diet or physical activity components

2019 Cochrane

12. Obesity in children

. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002 Jan;109(1):45-60. http://www.ncbi.nlm.nih.gov/pubmed/11773541?tool=bestpractice.com Worldwide, the definition of overweight and obesity changes; however, a BMI >85th percentile is defined as overweight or at risk for overweight in the US and UK, a BMI ≥95th percentile is variably defined as obesity or overweight, and a BMI >99th (...) percentile is defined as severe obesity. Barlow SE. Expert Committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007 Dec;120(suppl 4):S164-92. http://pediatrics.aappublications.org/content/120/Supplement_4/S164.full http://www.ncbi.nlm.nih.gov/pubmed/18055651?tool=bestpractice.com Canoy D, Bundred P. Obesity in children. BMJ Clin Evid. 2011 Apr 4;2011. pii: 0325. http://www.ncbi.nlm.nih.gov/pmc/articles

2019 BMJ Best Practice

13. The effect of the mandometer method in the treatment of eating disorders and obesity

The effect of the mandometer method in the treatment of eating disorders and obesity The effect of the mandometer method in the treatment of eating disorders and obesity We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Swedish Agency for Health Technology Assessment and Assessment of Social Services The effect of the mandometer method in the treatment of eating disorders and obesity Share: Reading time approx. 1 minute Eating (...) disorders such as anorexia nervosa and bulimia nervosa are a serious health problem in adolescents, especially for girls. At the same time, the problem of excessive obesity and obesity has grown into a public health problem. The mandometer method was developed as part of the treatment of eating disorders to teach patients to normalize their eating behavior and to recognize their hunger signals using a computer, a Mandometer. This method is now used to treat both eating disorders and obesity

2018 Swedish Council on Technology Assessement

14. Obesity

Obesity Evidence Maps - Trip Database or use your Google+ account Liberating the literature ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4) Loading

2018 Trip Evidence Maps

15. Cluster randomised controlled trial and economic and process evaluation to determine the effectiveness and cost effectiveness of a novel intervention [Healthy Lifestyles Programme (HeLP)] to prevent obesity in school children Full Text available with Trip Pro

Cluster randomised controlled trial and economic and process evaluation to determine the effectiveness and cost effectiveness of a novel intervention [Healthy Lifestyles Programme (HeLP)] to prevent obesity in school children Cluster randomised controlled trial and economic and process evaluation to determine the effectiveness and cost effectiveness of a novel intervention [Healthy Lifestyles Programme (HeLP)] to prevent obesity in school children Journals Library An error occurred retrieving (...) content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} The novel school-located Healthy Lifestyles Programme did not prevent obesity in 9-10 year olds at two year follow up. {{author}} {{($index

2018 NIHR HTA programme

16. Physical Activity: Interventions Including Activity Monitors for Adults with Overweight or Obesity

Physical Activity: Interventions Including Activity Monitors for Adults with Overweight or Obesity Phys Activity: Programs with Activity Monitors | The Community Guide Welcome to The Community Guide! Let us know what you think of the website by completing this . Open Navigation or Search form Search Search The Community Guide You are here » Systematic Review Topic Recommended (sufficient evidence) August 2017 Audience Adults Setting Clinical/Health Systems Workplace/Worksite Strategy Counseling (...) Health Education Technology-based Physical Activity: Interventions Including Activity Monitors for Adults with Overweight or Obesity Tabs Snapshot Summary of CPSTF Finding The interventions that include activity monitors to increase physical activity in adults with overweight or obesity. More research is needed, however, to determine whether changes in physical activity are maintained over time. Intervention Physical activity interventions that include activity monitors provide participants

2017 Community Preventive Services Task Force

17. What are the estimated costs of childhood overweight and obesity on the island of Ireland?

What are the estimated costs of childhood overweight and obesity on the island of Ireland? What are the estimated costs of childhood overweight and obesity on the island of Ireland?What are the estimated costs of childhood overweight and obesity on the island of Ireland? To be cited as Ivan J. Perry, Seán R. Millar, Kevin P. Balanda, Anne Dee, David Bergin, Laura Carter, Edel Doherty, Lorraine Fahy, Douglas Hamilton, Abbygail Jaccard, André Knuchel-Takano, Laura McCarthy, Adam McCune, Grace (...) O’Malley, Laura Pimpin, Michelle Queally and Laura Webber ISBN: 978-1-905767-75-5 Publication date: November 2017 What are the estimated costs of childhood overweight and obesity on the island of Ireland? Table of contents Table of contents 1 List of tables 3 List of figures 1 List of abbreviations 1 Acknowledgements 3 Executive summary 4 Introduction 4 Aims and objectives 5 Link with EU Joint Action on Nutrition and Physical Activity (JANPA) project 6 Literature review 6 Methods 11 Results 20

2018 Institute of Public Health in Ireland

18. Clinical Practice Guideline for the Behavioral Treatment of Obesity and Overweight in Children and Adolescents

Clinical Practice Guideline for the Behavioral Treatment of Obesity and Overweight in Children and Adolescents 1 CLINICAL PRACTICE GUIDELINE for Multicomponent Behavioral Treatment of Obesity and Overweight in Children and Adolescents Current State of the Evidence and Research Needs MARCH 20182 AMERICAN PSYCHOLOGICAL ASSOCIATION Copyright © 2018 by the American Psychological Association. This material may be reproduced and distributed without permission provid- ed that acknowledgment is given (...) at that time. It is available online at http:/ /www.apa.org/ obesity-guideline/ obesity.pdf. Suggested Citation American Psychological Association, Clinical Practice Guideline Panel. (2018). Clinical practice guideline for multicomponent behavioral treatment of obesity and overweight in children and adolescents: Current state of the evidence and research needs. Retrieved from http:/ /www.apa.org/ obesity-guideline/ obesity.pdfI CLINICAL PRACTICE GUIDELINE for Multicomponent Behavioral Treatment of Obesity

2018 American Psychological Association

19. Can mobile technology improve weight loss in overweight and obese patients?

Can mobile technology improve weight loss in overweight and obese patients? Can mobile technology improve weight loss in overweight and obese patients? Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work without it. Search MOspace This Collection Browse Statistics Can mobile technology improve weight loss in overweight and obese patients? View/ Open Date 2017-02 Format Metadata (...) Abstract Q: Can mobile technology improve weight loss in overweight and obese patients? Evidence-based answer: Yes, this technology can help in the short term. Mobile technology compared with minimal or no intervention increases short-term (<6 months) weight loss (1.4 to 2.7 kg) in overweight and obese patients (strength of recommendation [SOR]: A, meta-analysis of good quality studies and randomized controlled trials [RCTs]). Interventions that combine nonelectronic measures with mobile technology

2017 Clinical Inquiries

20. Gynaecologic Surgery in the Obese Patient

of obesity on gynaecologic surgery; and preoperative, intraoperative, and postoperative interventions to reduce risk. Evidence For this guideline, relevant studies were searched in the PubMed, EMBASE, Medline, and Cochrane databases. MeSH search terms included Gynecology, Obesity, Obesity/morbid, Overweight, Body mass index, Surgery, Laparoscopy, Laparotomy, Anesthesia, Intraoperative complications, Postoperative complications, Morbidity, and Mortality. Validation methods The content and recommendations (...) Gynaecologic Surgery in the Obese Patient Guideline No. 386-Gynaecologic Surgery in the Obese Patient - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 41, Issue 9, Pages 1356–1370.e7 Guideline No. 386-Gynaecologic Surgery in the Obese Patient x Paul J. Yong Correspondence Corresponding author: Dr. Paul Yong , MD , x Paul J. Yong Correspondence Corresponding author: Dr. Paul Yong Vancouver, BC x Jackie Thurston , MD

2019 Society of Obstetricians and Gynaecologists of Canada

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>